- Home
- RLMD vs AMRN Comparison
RLMD vs AMRN Comparison
Compare RLMD & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RLMD | AMRN |
|---|---|---|
| Founded | 2004 | 1989 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 319.7M | 339.8M |
| IPO Year | 2012 | 1998 |
Fundamental Metrics
Financial Performance| Metric | RLMD | AMRN |
|---|---|---|
| Price | $4.08 | $15.61 |
| Analyst Decision | Strong Buy | Strong Sell |
| Analyst Count | 3 | 1 |
| Target Price | $9.00 | ★ $12.00 |
| AVG Volume (30 Days) | ★ 620.1K | 63.4K |
| Earning Date | 03-05-2026 | 03-31-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 19.21 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $13,070.00 | ★ $181,104,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 154.83 | 39.22 |
| 52 Week Low | $0.24 | $0.35 |
| 52 Week High | $5.12 | $20.90 |
Technical Indicators
Market Signals| Indicator | RLMD | AMRN |
|---|---|---|
| Relative Strength Index (RSI) | 52.15 | 55.57 |
| Support Level | $3.81 | $14.48 |
| Resistance Level | $4.56 | $15.65 |
| Average True Range (ATR) | 0.35 | 0.73 |
| MACD | 0.04 | 0.08 |
| Stochastic Oscillator | 68.39 | 80.05 |
Price Performance
Historical ComparisonAbout RLMD Relmada Therapeutics Inc.
Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its key product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.
About AMRN Amarin Corporation plc
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.